Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial
Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: John Furler, David O'Neal, Jane Speight, Irene Blackberry, Jo-Anne Manski-Nankervis, Sharmala Thuraisingam, Katie de La Rue, Louise Ginnivan, Rebecca Doyle, Elizabeth Holmes-Truscott, Kamlesh Khunti, Kim Dalziel, Jason Chiang, Ralph Audehm, Mark Kennedy, Malcolm Clark, Alicia Jenkins, Amelia J Lake, Andrzej S Januszewski, Max Catchpool, Danny Liew, Philip Clarke, James Best
Institutions: The University of Melbourne, Deakin University, Diabetes Victoria, La Trobe University, University of Leicester, Leicester General Hospital, The University of Sydney, National Health and Medical Research Council, Monash University, Nanyang Technological University, Imperial College London
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Roche, Sanofi, Medtronic, Center for Outcomes Research and Evaluation, Yale School of Medicine, Boehringer Ingelheim, National Institute for Health and Care Research, Deakin University, Novo Nordisk, AstraZeneca Australia, Diabetes Victoria, Sanofi Australia, Abbott Diabetes Care, Manchester Biomedical Research Centre, National Health and Medical Research Council, Collaboration for Leadership in Applied Health Research and Care - Greater Manchester, National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care Yorkshire and Humber, NIHR Leicester Biomedical Research Centre, Sydney Medical School Foundation
OpenAlex ID: W2995952001
